| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3344 | |||||||||||||||||||||||
| Submitter : | Mrs. Caroline Haydu | Date & Time: | 12/15/2006 08:12:05 | |||||||||||||||||||||
| Organization : | Mrs. Caroline Haydu | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I am strenuously opposed to the use of aborted fetal cells as vaccine substrates. Ethical cell lines are available, are not in opposition to anyone's convictions, and are effective in vaccine development. | ||||||||||||||||||||||||